Bremzalerbart

N/A

Report date: 2026/02/27 20:01:47

Base Information

Drug NameBremzalerbart
Drug Alias NameREGN-5713REGN5713
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIgE receptors modulators
TargetsIgE receptors
Therapy Area/IndicationsConjunctivitis, AllergicConjunctivitisRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[5
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsConjunctivitis, AllergicConjunctivitisRhinitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A